DecisionPoint Financial’s Merck MRK Stock Holding History

DecisionPoint Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9K	Buy	143 +21	+17%	+$2.46K	﹤0.01%	164
2026 Q1	$14.7K	Sell	122 -15	-11%	-$1.73K	﹤0.01%	161
2025 Q4	$14.4K	Buy	137 +125	+1,042%	+$11.7K	﹤0.01%	166
2025 Q3	$1.08K	Sell	12 -1,000	-99%	-$82.4K	﹤0.01%	314
2025 Q2	$82.8K	Buy	1,012 +12	+1%	+$954	0.02%	68
2025 Q1	$89.8K	Hold	1,000	–	–	0.03%	60
2024 Q4	$99.5K	Hold	1,000	–	–	0.03%	58
2024 Q3	$114K	Hold	1,000	–	–	0.04%	48
2024 Q2	$113K	Hold	1,000	–	–	0.04%	47
2024 Q1	$131K	Hold	1,000	–	–	0.05%	43
2023 Q4	$109K	Hold	1,000	–	–	0.05%	41
2023 Q3	$103K	Hold	1,000	–	–	0.05%	35
2023 Q2	$115K	Hold	1,000	–	–	0.06%	33
2023 Q1	$106K	Hold	1,000	–	–	0.06%	35
2022 Q4	$111K	Buy	+1,000	New	+$102K	0.07%	32

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DecisionPoint Financial's MRK Position: Q2 2026 in Review

DecisionPoint Financial increased its Merck (MRK) stake by 17% in Q2 2026, buying an estimated $2.46K and bringing the position to 143 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

DecisionPoint Financial first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $131K in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

DecisionPoint Financial held 143 shares of Merck worth $17.9K as of Q2 2026.
DecisionPoint Financial bought 21 Merck shares in Q2 2026, an estimated $2.46K.
Merck made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #164 holding.
DecisionPoint Financial first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
DecisionPoint Financial's Merck position peaked at $131K in Q1 2024.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.